Wall Street analysts forecast that DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) will announce sales of $1.02 billion for the current quarter, according to Zacks. Eight analysts have provided estimates for DENTSPLY SIRONA’s earnings, with estimates ranging from $984.00 million to $1.04 billion. DENTSPLY SIRONA posted sales of $1.07 billion in the same quarter last year, which would indicate a negative year over year growth rate of 4.7%. The firm is scheduled to issue its next quarterly earnings results on Monday, January 1st.
On average, analysts expect that DENTSPLY SIRONA will report full-year sales of $4.14 billion for the current fiscal year, with estimates ranging from $4.13 billion to $4.15 billion. For the next financial year, analysts expect that the firm will post sales of $4.29 billion, with estimates ranging from $4.25 billion to $4.35 billion. Zacks’ sales averages are a mean average based on a survey of sell-side research analysts that follow DENTSPLY SIRONA.
DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last announced its quarterly earnings data on Tuesday, May 10th. The medical instruments supplier reported $0.52 EPS for the quarter, beating analysts’ consensus estimates of $0.50 by $0.02. The business had revenue of $9.67 billion during the quarter, compared to analyst estimates of $982.05 million. DENTSPLY SIRONA had a net margin of 8.81% and a return on equity of 11.63%. The firm’s revenue for the quarter was up 841.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.72 earnings per share.
NASDAQ:XRAY opened at $37.75 on Monday. DENTSPLY SIRONA has a 12-month low of $35.00 and a 12-month high of $68.82. The company has a quick ratio of 1.03, a current ratio of 1.45 and a debt-to-equity ratio of 0.38. The firm has a market capitalization of $8.13 billion, a PE ratio of 22.34 and a beta of 0.94. The firm has a 50-day moving average price of $44.51 and a 200 day moving average price of $50.43.
The company also recently announced a quarterly dividend, which was paid on Friday, April 8th. Shareholders of record on Friday, March 25th were issued a $0.125 dividend. The ex-dividend date was Thursday, March 24th. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.11. This represents a $0.50 annualized dividend and a yield of 1.32%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is 29.59%.
In other DENTSPLY SIRONA news, Director Eric Brandt sold 6,900 shares of the stock in a transaction on Tuesday, May 3rd. The shares were sold at an average price of $39.71, for a total value of $273,999.00. Following the sale, the director now directly owns 35,155 shares in the company, valued at $1,396,005.05. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 0.76% of the company’s stock.
Several large investors have recently modified their holdings of XRAY. NuWave Investment Management LLC raised its holdings in shares of DENTSPLY SIRONA by 172.8% during the fourth quarter. NuWave Investment Management LLC now owns 502 shares of the medical instruments supplier’s stock worth $28,000 after acquiring an additional 318 shares during the period. SOA Wealth Advisors LLC. grew its position in shares of DENTSPLY SIRONA by 26,666.7% in the 1st quarter. SOA Wealth Advisors LLC. now owns 803 shares of the medical instruments supplier’s stock valued at $39,000 after acquiring an additional 800 shares during the period. Parkside Financial Bank & Trust grew its position in shares of DENTSPLY SIRONA by 163.7% in the 1st quarter. Parkside Financial Bank & Trust now owns 915 shares of the medical instruments supplier’s stock valued at $46,000 after acquiring an additional 568 shares during the period. Dark Forest Capital Management LP bought a new position in shares of DENTSPLY SIRONA in the 3rd quarter valued at about $50,000. Finally, National Bank of Canada FI bought a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at about $55,000. Institutional investors and hedge funds own 94.79% of the company’s stock.
DENTSPLY SIRONA Company Profile (Get Rating)
DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces.
- Get a free copy of the StockNews.com research report on DENTSPLY SIRONA (XRAY)
- MarketBeat: Week in Review 5/16 – 5/20
- 3 Retailers That Defied First Quarter Headwinds
- Will John Deere’s Earnings Help to Calm the Markets?
- Rapid7: Could Be Profitable in FY 2022 Despite Bear Market
- Lowe’s Companies Has Not Bottomed
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.